TrialFrontiers in endocrinology2025

Effect of SY009, a novel SGLT1 inhibitor, on the plasma metabolome and bile acids in patients with type 2 diabetes mellitus.

Haoyi Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.